Ventricular Tachycardia/Ventricular Fibrillation Ablation in the Setting of Ischemic Heart Disease

Recurrent ventricular tachycardia (VT) in the setting of coronary artery disease is frequently a life‐threatening electrophysiologic emergency. Even in patients with an implantable defibrillator, recurrent VT is frequently accompanied by repeated and disabling shock therapy. Catheter ablative therap...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cardiovascular electrophysiology 2005-09, Vol.16 (s1), p.S59-S70
Main Authors: MARCHLINSKI, FRANCIS, GARCIA, FERMIN, SIADATAN, AMIR, SAUER, WILLIAM, BELDNER, STUART, ZADO, ERICA, HSIA, HENRY, LIN, DAVID, COOPER, JOSHUA, VERDINO, RALPH, GERSTENFELD, EDWARD, DIXIT, SANJAY, RUSSO, ANDREA, CALLANS, DAVID
Format: Article
Language:English
Subjects:
cardiac mapping
catheter ablation
Catheter Ablation - methods
Humans
Myocardial Ischemia - complications
Myocardial Ischemia - surgery
Practice Guidelines as Topic
Practice Patterns, Physicians
Secondary Prevention
Tachycardia, Ventricular - etiology
Tachycardia, Ventricular - prevention & control
Treatment Outcome
Ventricular Fibrillation - etiology
Ventricular Fibrillation - prevention & control
ventricular tachycardia
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recurrent ventricular tachycardia (VT) in the setting of coronary artery disease is frequently a life‐threatening electrophysiologic emergency. Even in patients with an implantable defibrillator, recurrent VT is frequently accompanied by repeated and disabling shock therapy. Catheter ablative therapy offers the ability to provide immediate control of recurrent VT. Long‐term elimination of VT should be anticipated in most patients. This article reviews the strategies, tools, techniques, and expected outcome for catheter ablation of stable and unstable ventricular arrhythmias in the setting ischemic heart disease.
ISSN:1045-3873
1540-8167
DOI:10.1111/j.1540-8167.2005.50210.x